CRNX
Price
$35.61
Change
+$1.36 (+3.97%)
Updated
Sep 5 closing price
Capitalization
3.23B
61 days until earnings call
JANX
Price
$23.98
Change
+$0.04 (+0.17%)
Updated
Sep 5 closing price
Capitalization
1.44B
66 days until earnings call
Interact to see
Advertisement

CRNX vs JANX

Header iconCRNX vs JANX Comparison
Open Charts CRNX vs JANXBanner chart's image
Crinetics Pharmaceuticals
Price$35.61
Change+$1.36 (+3.97%)
Volume$1.42M
Capitalization3.23B
Janux Therapeutics
Price$23.98
Change+$0.04 (+0.17%)
Volume$429.79K
Capitalization1.44B
CRNX vs JANX Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. JANX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and JANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CRNX: $35.61 vs. JANX: $23.98)
Brand notoriety: CRNX and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 149% vs. JANX: 58%
Market capitalization -- CRNX: $3.23B vs. JANX: $1.44B
CRNX [@Biotechnology] is valued at $3.23B. JANX’s [@Biotechnology] market capitalization is $1.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, CRNX is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 5 TA indicator(s) are bullish while JANX’s TA Score has 4 bullish TA indicator(s).

  • CRNX’s TA Score: 5 bullish, 5 bearish.
  • JANX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than JANX.

Price Growth

CRNX (@Biotechnology) experienced а +14.91% price change this week, while JANX (@Biotechnology) price change was +5.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

CRNX is expected to report earnings on Nov 06, 2025.

JANX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.23B) has a higher market cap than JANX($1.44B). CRNX YTD gains are higher at: -30.354 vs. JANX (-55.211). JANX has higher annual earnings (EBITDA): -142.8M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. JANX (996M). JANX has less debt than CRNX: JANX (22.2M) vs CRNX (49.9M). CRNX has higher revenues than JANX: CRNX (1.39M) vs JANX (439K).
CRNXJANXCRNX / JANX
Capitalization3.23B1.44B224%
EBITDA-419.62M-142.8M294%
Gain YTD-30.354-55.21155%
P/E RatioN/AN/A-
Revenue1.39M439K317%
Total Cash1.2B996M120%
Total Debt49.9M22.2M225%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXJANX
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 17 days ago
77%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ATWYX25.42N/A
N/A
AB Tax-Managed Wealth Apprec Strat Adv
FFALX16.96N/A
N/A
Franklin Global Allocation A
GLNIX25.31N/A
N/A
MFS Global New Discovery I
BRULX16.86N/A
N/A
MFS Blended Research Value Equity R3
JGTTX41.92N/A
N/A
JPMorgan Growth Advantage R3

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with SKYE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+0.17%
SKYE - JANX
41%
Loosely correlated
+6.67%
CRNX - JANX
39%
Loosely correlated
+3.97%
RCUS - JANX
39%
Loosely correlated
+5.45%
SYRE - JANX
38%
Loosely correlated
+0.06%
CGON - JANX
38%
Loosely correlated
+6.88%
More